Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatc (Q74674032)
Jump to navigation
Jump to search
scientific article published on 01 September 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatc |
scientific article published on 01 September 2002 |
Statements
Treatment of high-risk acute myelogenous leukaemia by myeloablative chemoradiotherapy followed by co-infusion of T cell-depleted haematopoietic stem cells and culture-expanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype (English)
Seung Tae Lee
Joon Ho Jang
Jin Seok Kim
Ho-Young Maemg
Jee Sook Hahn
1 September 2002